Red blood cells require efficient iron uptake and meticulous coordination or iron acquisition, globin protein production and heme biosynthesis. This is accomplished, at least in part, through a regulated surge in the number of cell surface transferrin receptors (TfRs) just prior to the start of hemoglobinization. Though it is widely believed that the transferring cycle is important for iron uptake by all mammalian cells, this may not be the case. Must studies of the transferring cycle have been carried out in erythroid cells and tumor cell lines. The work proposed in this application investigates the hypothesis that the primary function of the TfR is not to deliver iron ubiquitously, but rather to increase the efficiency of iron transport into erythroid cells, through a process that is tightly coupled to erythroid maturation. To this end, embryonic stem cells have been produced that carry a targeted disruption of the TfR gene. These cells have been introduced into the mouse germline, to produce mutant animals. Consistent with the hypothesis stated above, TfR-/- animals die early in gestation, apparently of severe anemia. The goal of this proposal is to characterize the role of the TfR more fully.
Specific aims are (1) to determine which tissues have an absolute requirement for the TfR for normal development, (2) to understand how the TfR and transferrin cycle contribute to the regulation of erythroid differentiation and (3) to investigate the role of the TfR in regulation of body iron stores. This will be accomplished through further analysis of TfR-/- animals, through examination of the TfR mutation in the context of other mutations known to affect iron metabolism, and through in vitro differentiation and characterization of TfR-/- cells. The insights gained from this work are likely to improve our understanding of both iron deficiency and iron overload disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051057-08
Application #
6330064
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Thomas, John
Project Start
1993-12-01
Project End
2003-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
8
Fiscal Year
2001
Total Cost
$195,113
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Li, Jau Yi; Paragas, Neal; Ned, Renee M et al. (2009) Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 16:35-46
Carlson, Erik S; Tkac, Ivan; Magid, Rhamy et al. (2009) Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr 139:672-9
Andrews, Nancy C (2008) Forging a field: the golden age of iron biology. Blood 112:219-30
Zhu, Bing-Mei; McLaughlin, Sara K; Na, Risu et al. (2008) Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. Blood 112:2071-80
Ned, Renee M; Swat, Wojciech; Andrews, Nancy C (2003) Transferrin receptor 1 is differentially required in lymphocyte development. Blood 102:3711-8
Andrews, Nancy C (2002) A genetic view of iron homeostasis. Semin Hematol 39:227-34
Levy, J E; Montross, L K; Andrews, N C (2000) Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 105:1209-16